The multibillion-dollar trial will determine whether the Israeli company contributed to an opioid crisis that has caused more than 500,000 deaths over the past two decades.
A national membership association that provides education and advocacy for those in the behavioral health and addiction treatment industries.
We are the leading and unifying voice of addiction-focused treatment programs.
Please enter your username or email address. You will receive a link to create a new password via email.
Get New Password
Please enter your email. You'll receive an email with your one-time use Snappy Login Link™. Just click the link within 30 minutes to automatically login.
Get Snappy Login Link™